Lifecore Biomedical (LFCR) Income Statement: Revenue & Earnings

Lifecore Biomedical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Lifecore Biomedical, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	May 2024	May 2023	May 2022	May 2021	May 2020	May 2019	May 2018
Revenue & Gross Profit
Revenue	128.87	128.26	103.27	111.27	100.87	0.00	557.56	524.23
Cost of Revenue	88.57	86.41	75.28	72.20	61.94	515.38	476.56	445.89
Gross Profit	40.30	41.85	27.99	39.07	38.94	-515.38	-476.56	-445.89
Operating Expenses
Research & Development	8.26	8.58	8.74	7.84	7.42	11.10	11.47	12.80
Selling, General & Administrative	44.05	40.46	38.97	34.66	37.66	81.79	67.29	51.95
Operating Expenses	57.54	49.04	47.71	42.50	50.61	92.89	78.76	64.75
Operating Income	-17.25	-7.19	-19.72	-3.43	-0.13	-608.27	-555.31	-510.64
Other Income/Expense
Interest Income	0.00	0.00	0.07	0.08	0.05	0.00	0.00	0.00
Interest Expense	21.84	18.09	17.58	15.47	-8.93	0.00	0.00	0.00
Other Income/Expense	-21.43	34.79	-26.63	-1.79	1.00	-587.10	-560.81	-528.78
Income
Income Before Tax	-38.67	9.51	-63.93	-20.69	-11.47	-51.31	3.64	16.40
Income Tax Expense	0.04	0.18	0.31	-5.21	-6.35	-13.12	1.52	-9.36
Net Income	-38.72	12.01	-99.56	-116.72	-32.29	-38.19	0.41	24.83
Net Income - Continuous Operations	-38.72	9.33	-64.24	-15.48	0.00	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	2.68	-35.33	-101.24	0.00	0.00	0.00	0.00
EBITDA	-8.81	35.56	-33.17	12.84	-0.99	-32.83	18.87	28.81
EBIT	-16.84	27.60	-46.35	-5.22	-20.85	-51.67	3.64	16.40
Depreciation & Amortization	8.03	7.95	13.18	18.06	19.87	-16.30	-13.10	-11.00
Earnings Per Share
Basic EPS	-1.00	-	-3.00	-3.00	-1.00	-	-	-
Diluted EPS	-1.00	-	-3.00	-3.00	-1.00	-1.00	-	1.00
Basic Shares Outstanding	34.82	30.47	29.97	29.51	29.29	29.16	28.36	27.54
Diluted Shares Outstanding	34.82	36.66	29.97	29.51	29.29	29.16	28.61	27.92